Annual Shareholders Equity
$26.38 M
-$13.18 M-33.32%
December 31, 2023
Summary
- As of February 8, 2025, COCP annual stockholders equity is $26.38 million, with the most recent change of -$13.18 million (-33.32%) on December 31, 2023.
- During the last 3 years, COCP annual shareholders equity has fallen by -$26.12 million (-49.75%).
- COCP annual shareholders equity is now -84.26% below its all-time high of $167.59 million, reached on December 31, 2015.
Performance
COCP Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$12.70 M
-$4.69 M-26.95%
September 30, 2024
Summary
- As of February 8, 2025, COCP quarterly stockholders equity is $12.70 million, with the most recent change of -$4.69 million (-26.95%) on September 30, 2024.
- Over the past year, COCP quarterly shareholders equity has dropped by -$17.99 million (-58.61%).
- COCP quarterly shareholders equity is now -93.54% below its all-time high of $196.75 million, reached on September 30, 2015.
Performance
COCP Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
COCP Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -33.3% | -58.6% |
| 3 y3 years | -49.8% | -67.9% |
| 5 y5 years | -60.5% | -67.9% |
COCP Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -66.0% | at low | -83.6% | at low |
| 5 y | 5-year | -66.0% | +2.6% | -85.0% | at low |
| alltime | all time | -84.3% | +398.7% | -93.5% | +221.5% |
Cocrystal Pharma Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $12.70 M(-27.0%) |
| Jun 2024 | - | $17.39 M(-23.0%) |
| Mar 2024 | - | $22.59 M(-14.4%) |
| Dec 2023 | $26.38 M(-33.3%) | $26.38 M(-14.0%) |
| Sep 2023 | - | $30.69 M(-11.5%) |
| Jun 2023 | - | $34.68 M(+0.0%) |
| Mar 2023 | - | $34.67 M(-12.4%) |
| Dec 2022 | $39.57 M(-49.0%) | $39.57 M(-9.9%) |
| Sep 2022 | - | $43.91 M(-11.1%) |
| Jun 2022 | - | $49.39 M(-32.9%) |
| Mar 2022 | - | $73.58 M(-5.1%) |
| Dec 2021 | $77.55 M(+47.7%) | $77.55 M(-4.3%) |
| Sep 2021 | - | $81.01 M(-4.4%) |
| Jun 2021 | - | $84.75 M(+62.8%) |
| Mar 2021 | - | $52.06 M(-0.9%) |
| Dec 2020 | $52.51 M(+104.2%) | $52.51 M(+4.6%) |
| Sep 2020 | - | $50.18 M(+35.4%) |
| Jun 2020 | - | $37.05 M(-8.4%) |
| Mar 2020 | - | $40.43 M(+57.3%) |
| Dec 2019 | $25.71 M(-61.6%) | $25.71 M(-63.7%) |
| Sep 2019 | - | $70.75 M(-2.3%) |
| Jun 2019 | - | $72.42 M(-1.9%) |
| Mar 2019 | - | $73.82 M(+10.4%) |
| Dec 2018 | $66.89 M(-36.5%) | $66.89 M(-39.7%) |
| Sep 2018 | - | $110.90 M(-1.5%) |
| Jun 2018 | - | $112.65 M(+8.2%) |
| Mar 2018 | - | $104.14 M(-1.2%) |
| Dec 2017 | $105.40 M(+3.0%) | $105.40 M(+5.4%) |
| Sep 2017 | - | $100.00 M(-2.0%) |
| Jun 2017 | - | $102.04 M(+2.1%) |
| Mar 2017 | - | $99.98 M(-2.3%) |
| Dec 2016 | $102.32 M | $102.32 M(-39.0%) |
| Sep 2016 | - | $167.82 M(+0.6%) |
| Jun 2016 | - | $166.83 M(-1.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2016 | - | $169.34 M(+1.0%) |
| Dec 2015 | $167.59 M(+2419.8%) | $167.59 M(-14.8%) |
| Sep 2015 | - | $196.75 M(+0.1%) |
| Jun 2015 | - | $196.52 M(+4.1%) |
| Mar 2015 | - | $188.70 M(+2737.1%) |
| Dec 2014 | $6.65 M(-175.3%) | $6.65 M(+67.2%) |
| Sep 2014 | - | $3.98 M(-34.3%) |
| Jun 2014 | - | $6.06 M(-392.0%) |
| Mar 2014 | - | -$2.07 M(-76.5%) |
| Dec 2013 | -$8.83 M(+146.7%) | -$8.83 M(-15.5%) |
| Sep 2013 | - | -$10.45 M(+96.9%) |
| Jun 2013 | - | -$5.31 M(+5.0%) |
| Mar 2013 | - | -$5.06 M(+41.2%) |
| Dec 2012 | -$3.58 M(+29.3%) | -$3.58 M(+4680.1%) |
| Sep 2012 | - | -$74.90 K(-98.1%) |
| Jun 2012 | - | -$3.93 M(-31.8%) |
| Mar 2012 | - | -$5.77 M(+108.2%) |
| Dec 2011 | -$2.77 M(+370.0%) | -$2.77 M(+1458.3%) |
| Sep 2011 | - | -$177.70 K(-148.5%) |
| Jun 2011 | - | $366.30 K(+5904.9%) |
| Mar 2011 | - | $6100.00(-101.0%) |
| Dec 2010 | -$589.20 K(-1131.9%) | -$589.20 K(-3250.8%) |
| Sep 2010 | - | $18.70 K(-45.6%) |
| Jun 2010 | - | $34.40 K(-36.5%) |
| Mar 2010 | - | $54.20 K(-5.1%) |
| Dec 2009 | $57.10 K(-41.0%) | $57.10 K(-15.3%) |
| Sep 2009 | - | $67.40 K(-7.8%) |
| Jun 2009 | - | $73.10 K(-8.5%) |
| Mar 2009 | - | $79.90 K(-17.4%) |
| Dec 2008 | $96.70 K(-34.6%) | $96.70 K(-7.8%) |
| Sep 2008 | - | $104.90 K(-7.3%) |
| Jun 2008 | - | $113.20 K(-11.0%) |
| Mar 2008 | - | $127.20 K(-13.9%) |
| Dec 2007 | $147.80 K | $147.80 K |
FAQ
- What is Cocrystal Pharma annual stockholders equity?
- What is the all time high annual shareholders equity for Cocrystal Pharma?
- What is Cocrystal Pharma annual shareholders equity year-on-year change?
- What is Cocrystal Pharma quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Cocrystal Pharma?
- What is Cocrystal Pharma quarterly shareholders equity year-on-year change?
What is Cocrystal Pharma annual stockholders equity?
The current annual shareholders equity of COCP is $26.38 M
What is the all time high annual shareholders equity for Cocrystal Pharma?
Cocrystal Pharma all-time high annual stockholders equity is $167.59 M
What is Cocrystal Pharma annual shareholders equity year-on-year change?
Over the past year, COCP annual stockholders equity has changed by -$13.18 M (-33.32%)
What is Cocrystal Pharma quarterly stockholders equity?
The current quarterly shareholders equity of COCP is $12.70 M
What is the all time high quarterly shareholders equity for Cocrystal Pharma?
Cocrystal Pharma all-time high quarterly stockholders equity is $196.75 M
What is Cocrystal Pharma quarterly shareholders equity year-on-year change?
Over the past year, COCP quarterly stockholders equity has changed by -$17.99 M (-58.61%)